April 23, 2023
1 min read
Save
Neuspera Medical receives FDA clearance of micro-implant neurostimulation therapy system
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Key takeaways:
- Neuspera Medical has announced FDA clearance of its Neuspera ultra-miniaturized system.
- The system utilizes a wireless platform and wearable device to provide peripheral nerve stimulation.
Neuspera Medical has announced FDA clearance of its Neuspera ultra-miniaturized neurostimulation therapy system, according to a company press release.
The Neuspera ultra-miniaturized system utilizes a wireless platform and wearable device to provide peripheral nerve stimulation for patients with chronic pain.
“We look forward to bringing this innovative technology to physicians and patients in the U.S.,” Steffen Hovard, CEO of Neuspera Medical, said in the release. “The Neuspera ultra-miniaturized system has the potential to revolutionize the way physicians treat patients battling chronic pain while restoring patients’ health and quality of life,” Hovard added.
Published by:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.